RESUMEN
OBJECTIVES: Family studies typically use multiple sources of information on each individual including direct interviews and family history information. The aims of the present study were to: (1) assess agreement for diagnoses of specific substance use disorders between direct interviews and the family history method; (2) compare prevalence estimates according to the two methods; (3) test strategies to approximate prevalence estimates according to family history reports to those based on direct interviews; (4) determine covariates of inter-informant agreement; and (5) identify covariates that affect the likelihood of reporting disorders by informants. METHODS: Analyses were based on family study data which included 1621 distinct informant (first-degree relatives and spouses) - index subject pairs. RESULTS: Our main findings were: (1) inter-informant agreement was fair to good for all substance disorders, except for alcohol abuse; (2) the family history method underestimated the prevalence of drug but not alcohol use disorders; (3) lowering diagnostic thresholds for drug disorders and combining multiple family histories increased the accuracy of prevalence estimates for these disorders according to the family history method; (4) female sex of index subjects was associated with higher agreement for nearly all disorders; and (5) informants who themselves had a history of the same substance use disorder were more likely to report this disorder in their relatives, which entails the risk of overestimation of the size of familial aggregation. CONCLUSION: Our findings have important implications for the best-estimate procedure applied in family studies.
Asunto(s)
Anamnesis/métodos , Trastornos Relacionados con Sustancias/diagnóstico , Trastornos Relacionados con Sustancias/epidemiología , Adulto , Alcoholismo/diagnóstico , Alcoholismo/epidemiología , Algoritmos , Recolección de Datos , Interpretación Estadística de Datos , Métodos Epidemiológicos , Familia , Femenino , Dependencia de Heroína/diagnóstico , Dependencia de Heroína/epidemiología , Humanos , Entrevista Psicológica , Masculino , Abuso de Marihuana/diagnóstico , Abuso de Marihuana/epidemiología , Persona de Mediana Edad , Oportunidad Relativa , Escalas de Valoración PsiquiátricaRESUMEN
OBJECTIVE: Several case-control studies examined an association between schizophrenia and the 40-bp variable number tandem repeat (VTNR) polymorphism in the 3'-UTR of the dopamine transporter gene (SLC6A3). The results of these studies have been equivocal due to small sample size and low power. This meta-analysis has the aim to evaluate the collective evidence for an association between the VTNR polymorphism and schizophrenia. METHOD: Different meta-analyses were performed, sequentially considering the 9- and 10-repeat alleles and different genotypes (genotypes 9/9, 9/10, 10/10) as risk factors for schizophrenia. Analyses of the alleles included 659 cases and 563 controls from six case-control studies. RESULTS: The pooled OR from each analysis approximated 1.0, and none were significant. Lack of significance attributable to the negative effects of single large studies or to heterogeneity between the studies was excluded. CONCLUSION: Despite over 90% power to detect a significant odds ratio as small as 1.3, no association was observed. Considering the cumulative evidence from six case-control studies and results from additional family-based studies, it seems unlikely that the 40-base-pair VTNR polymorphism of the SLC6A3 gene influences risk for schizophrenia.
Asunto(s)
Glicoproteínas de Membrana/genética , Proteínas de Transporte de Membrana/genética , Repeticiones de Minisatélite/genética , Proteínas del Tejido Nervioso/genética , Polimorfismo Genético/genética , Esquizofrenia/genética , Alelos , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática , Genotipo , Humanos , Oportunidad Relativa , Factores de RiesgoRESUMEN
Many medical groups may not regularly seek legal advice in regard to all the various business transactions in which they participate. Unlike hospitals, medical groups do not usually retain specialized health care law firms. As this professional paper illustrates, it is important for medical group administrators to have some familiarity with antitrust issues. This knowledge is important for administrators in two contexts: First, to keep their own groups from having antitrust problems; and second, to keep a watch on their competitors to be sure that the group's position is not compromised by any illegal activities engaged in by these entities.